RAPP peer analysis
Rapport Therapeutics (RAPP) against its competitors: price, today's move, 1-year return and market value side by side.
RAPP and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACAD Acadia Pharmaceuticals | $21.23 | -0.05% | -4.93% | $3.66B |
| ANRO Alto Neuroscience | $25.03 | 14.45% | 121.70% | – |
| AXSM Axsome Therapeutics | $132.37 | 1.98% | -2.45% | $6.93B |
| CGTX Cognition Therapeutics | $0.64 | -7.01% | -62.40% | – |
| CTNM Contineum Therapeutics | $9.52 | 8.06% | -8.81% | – |
| LBRX LB Pharmaceuticals | $42.50 | 11.58% | 162.35% | – |
| MPLT MapLight Therapeutics | $7.60 | 22.19% | -52.50% | – |
| NMRA Neumora Therapeutics | $0.49 | -13.96% | -81.41% | – |
| PRAX Praxis Precision Medicines | $279.00 | 6.25% | 69.46% | – |
| SPTX Seaport Therapeutics | $21.50 | 5.44% | – | – |
| RAPP Rapport Therapeutics | $24.44 | 3.04% | -6.61% | – |
- RAPP's peers: ACAD (Acadia Pharmaceuticals), ANRO (Alto Neuroscience), AXSM (Axsome Therapeutics), CGTX (Cognition Therapeutics), CTNM (Contineum Therapeutics), LBRX (LB Pharmaceuticals), MPLT (MapLight Therapeutics), NMRA (Neumora Therapeutics).
Updated 2026-11-07 11:53 UTC